Health-related statements according to EU Regulation 1924/2006 (approved health claims for the contained nutrients) The following statements are scientifically substantiated for the nutrients contained in Glutathion comp and approved by the European Food Safety Authority (EFSA): Zinc contributes to normal macronutrient metabolism contributes to normal protein synthesis contributes to normal DNA synthesis contributes to normal cognitive function contributes to the normal function of the immune system helps protect cells from oxidative stress has a role in the process of cell division Selenium contributes to the normal function of the immune system contributes to normal thyroid function helps protect cells from oxidative stress Vitamin B1 (Thiamine) contributes to normal energy-yielding metabolism contributes to the normal function of the nervous system contributes to normal psychological function contributes to normal heart function Vitamin B2 (Riboflavin) contributes to normal energy-yielding metabolism contributes to the normal function of the nervous system contributes to normal iron metabolism helps protect cells from oxidative stress contributes to the reduction of tiredness and fatigue Vitamin B3 (Niacin) contributes to normal energy-yielding metabolism contributes to the normal function of the nervous system contributes to normal psychological function contributes to the reduction of tiredness and fatigue Glutathione, AC, Alpha-Lipoic Acid Currently, no specific health claims are approved for these nutrients in the EU regulation

10.13702/j.1000-0607.20230017 146 LiuW.JiaC.LuoL.WangH
Never again
FOXO4-DRI is among the highest-risk research peptides from an evidence-to-risk standpoint: it has never been tested in humans, no human pharmacokinetic data exists, and as a senolytic it carries theoretical risks specific to its mechanism
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
It requires neurotrophic support, reduced inflammation, and sufficient neural substrate, meaning enough surviving and newly generated neurons to form the new pathways needed for functional recovery